Acm Research, INC Form 4 insider transactions

Chenming Hu, a director at ACM Research, sold 163,308 shares of Class A Common Stock at $30 per share on March 17, 2025, under a pre-arranged 10b5-1 trading plan.

Haiping Dun, a director at ACM Research, executed sales of Class A Common Stock on March 14, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Mark McKechnie, CFO of ACM Research, exercised stock options and sold shares of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

David H. Wang, a director at ACM Research, executed multiple sales of Class A Common Stock between March 11 and March 13, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Haiping Dun, a director at ACM Research, sold 15,001 shares of Class A Common Stock on March 10, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Director Haiping Dun of ACM Research, Inc. exercised stock options and reported changes in beneficial ownership of Class A Common Stock on March 3, 2025.

ACM Research CEO David H. Wang exercised stock options to acquire 210,000 shares of Class A Common Stock on March 3, 2025.

Sotheara Cheav, a Senior Vice President at ACM Research, exercised stock options and sold shares of Class A Common Stock on February 6, 2025.

Mark McKechnie, CFO of ACM Research, exercised stock options and sold shares of Class A Common Stock according to a pre-arranged Rule 10b5-1 trading plan.

Haiping Dun, a director at ACM Research, sold 19,058 shares of Class A Common Stock at an average price of $17.43, as part of a pre-arranged trading plan.

ACM Research CEO David Wang sold 56,250 shares of Class A Common Stock at an average price of $17.44, according to a recent SEC filing.

ACM Research CEO David Wang sold a total of 56,250 shares of Class A Common Stock in multiple transactions under a pre-arranged 10b5-1 trading plan.

ACM Research director Haiping Dun sold 15,000 shares of Class A Common Stock at an average price of $19.12, according to a recent SEC filing.

ACM Research CEO David Wang sold 56,250 shares of Class A Common Stock at an average price of $19.08, according to a recent SEC filing.

Director Haiping Dun of ACM Research exercised stock options, resulting in a net increase of 34,058 shares of Class A Common Stock and a decrease of 942 shares to cover the exercise price.

ACM Research CEO David H. Wang exercised stock options, resulting in the acquisition of 262,738 shares of Class A Common Stock after a cashless exercise.

Shanghai Science & Technology Venture Capital (Group) Co., Ltd. sold shares of ACM Research (ACMR) between October 4 and October 8, 2024, reducing its direct holdings.

Director Xiao Xing, an employee of an affiliate of Shanghai Science and Technology Venture Capital Co., Ltd. (SSTVC), sold shares of ACM Research, Inc. under a pre-arranged 10b5-1 trading plan.

Mark McKechnie, an officer at ACM Research, exercised stock options and sold shares of Class A Common Stock according to a pre-arranged trading plan.

Shanghai Science & Technology Venture Capital (Group) Co., Ltd. disposed of shares of ACM Research, Inc. on October 1st and 2nd, 2024, according to a Form 4 filing.

Director Xiao Xing, associated with Shanghai Science and Technology Venture Capital Co., Ltd. (SSTVC), sold shares of ACM Research, Inc. under a pre-arranged 10b5-1 trading plan.

Fuping Chen, Vice President, Sales-China of ACM Research (Shanghai), Inc., acquired 30,000 shares of ACM Research, Inc. through the vesting of a stock option.

Director Haiping Dun of ACM Research, Inc. sold 19,097 shares of Class A Common Stock at an average price of $18.08 on August 29, 2024, under a pre-arranged 10b5-1 trading plan.

Haiping Dun, a director at ACM Research, Inc., sold 15,000 shares of Class A Common Stock on August 22, 2024, at a weighted average price of $19.85.

Director Tracy Liu acquired 20,000 stock options in ACM Research, Inc. on August 12, 2024.

Director Haiping Dun of ACM Research, Inc. acquired 20,000 stock options on August 12, 2024, exercisable prior to the 2025 annual meeting.

Director Chenming Hu of ACM Research, Inc. was granted 20,000 stock options on August 12, 2024, exercisable prior to the 2025 annual meeting.

Director Haiping Dun exercised stock options in ACM Research, resulting in the acquisition and disposal of shares to cover the exercise price.

Director Haiping Dun gifted 100,000 shares of Class A Common Stock and 300,000 shares of Class B Common Stock to the Dun Family GST Trust on June 27, 2024.

Jian Wang, a key executive at ACM Research, recently exercised stock options and sold a portion of the acquired shares under a pre-arranged trading plan.